MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer. 2020

Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
Department of Gynecologic and Obstetrics, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471000, Henan, China.

Long non-coding RNAs (lncRNAs) play important roles in the progression of cervical cancer (CC). However, the roles and underlying molecular mechanisms of lncRNAs in CC remain unclear. In the current study, we discovered a new lncRNA MIR210HG which was upregulated in CC tissues through microarray. The upregulation of MIR210HG was associated with advanced FIGO stage, metastasis, and poor prognosis in CC patients. Function assays showed that MIR210HG inhibition significantly suppressed the proliferation, invasion, and epithelial-mesenchymal transition (EMT) processes in CC and reduced tumor growth in vivo. Mechanistically, we identified that MIR210HG might serve as a competing endogenous RNA (ceRNA) of miR-503-5p to relieve the repressive effect of miR-503-5p on TRAF4 expression in CC cells. In conclusion, we demonstrated that MIR210HG promoted CC progression through regulating the MIR210HG/miR-503-5p/TRAF4 axis, indicating that MIR210HG might act as a novel insight into CC treatment.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
May 2019, Cell cycle (Georgetown, Tex.),
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
June 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
May 2021, Molecular medicine reports,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
May 2021, Acta biochimica et biophysica Sinica,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
January 2020, OncoTargets and therapy,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
May 2020, Neoplasma,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
February 2023, Molecular medicine reports,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
November 2020, Pathology, research and practice,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
May 2019, European review for medical and pharmacological sciences,
Ai-Hong Wang, and Can-Hui Jin, and Guan-Yi Cui, and Hong-Yu Li, and Yin Wang, and Juan-Juan Yu, and Rui-Fang Wang, and Xiao-Yu Tian
October 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!